On November 19, 2024, a rule was published by the Drug Enforcement Agency and the Health and Human Services Department that extends the COVID-19 telehealth flexibility for the prescription of controlled medications. This flexibility was set to end this year, but has been extended until December 31, 2025, to allow the DEA and HHS to continue work on final regulations.
Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
Nov 19, 2024